Skip to main content
. 2020 Aug 20;10:14054. doi: 10.1038/s41598-020-70944-9

Table 1.

Baseline ocular surface parameters of Rheumatoid Arthritis (RA) patients compared to healthy controls.

RA patients (n = 16) Control (n = 24) p
OSDI (score) 22.9 (11.4–41.7) 1.0 (0–8.3) 0.007
OSDI abnomal, n (%) 11 (68.8) 4 (16.7) 0.002
Schirmer (mm/5 min) 14.5 (10–20) 27 (17–33) 0.005
Schirmer < 10 mm, n (%) 6 (37.5) 2 (8.3) 0.042
TBUT (seconds) 9 (6–12) 8 (6.5–10) 0.70
TBUT < 10 s, n (%) 11 (68.8) 15 (62.5) 0.68
Fluorescein (score) 0 (0–0) 0 (0–0) 0.99
Lissamine green (score) 0 (0–0) 0 (0–0) 0.65
MGD, n (%) 8 (50) 2 (8.3) 0.007
IC (score) 1 (0.5–2) 0 (0–0) < 0.001
IC abnomal, n (%) 12 (75) 2 (8.3)   0.001
GCC (cells/mm2) 325 (274–707) 742 (562–863) 0.004
Dry eye, n (%) 13 (81.3) 1 (4.2) < 0.001
Severity, n
Absent 3 (18.7) 23 (95.8)
Mild 12 (75) 1 (4.2) < 0.001
Moderate 1 (6.3) 0

Data are expressed as medians (interquartile range) or absolute numbers (percentage). RA rheumatoid arthritis, OSDI Ocular Surface Disease Index (range 0–100), mm millimeters; Schirmer’s test range 0–35 mm, TBUT tear break-up time; Fluorescein and Lissamine green scores range 0–9, MGD meibomian gland dysfunction, IC impression cytology (range 0–3), GCC goblet cell count; Bold values: statistical significance = p < 0.05.